Список литературы

1. Gardiner FW, McCuaig R, Arthur C, Carins T et al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review.//Obs. Med. 2019. Vol. 12(3): 123-.

2. Ovadia C., Williamson C. Intrahepatic cholestasis of pregnancy: Recent advances.//Clin. Dermatol. 2016. Vol. 34, N 3. P. 327 - 334.

3. Geenes V. et al. Association of severe intrahepatic cholestasis of pregnancy with adverse pregnancy outcomes: a prospective population-based case-control study.//Hepatology. 2014. Vol. 59, N 4. P. 1482 - 1491.

4. Gardiner FW, McCuaig R, Arthur C, Carins T M.A. al. The prevalence and pregnancy outcomes of intrahepatic cholestasis of pregnancy: A retrospective clinical audit review//Obs. Med. 2019. Vol. 12(3): 123-.

5. Diken Z., Usta I.M., Nassar A.H. A clinical approach to intrahepatic cholestasis of pregnancy.//Am. J. Perinatal. 2014. Vol. 31, N 1. P. 1 - 8.

6. Lindor K.D., Lee R.H. Intrahepatic cholestasis of pregnancy.//UpToDate. 2019.

7. Furrer R. et al. Postpartum Blood Loss in Women Treated for Intrahepatic Cholestasis of Pregnancy.//Obstet. Gynecol. 2016. Vol. 128, N 5. P. 1048 - 1052.

8. Bicocca M.J., Sperling J.D., Chauhan S.P. Intrahepatic cholestasis of pregnancy: Review of six national and regional guidelines.//Eur. J. Obstet. Gynecol. Reprod. Biol. 2018. Vol. 231. P. 180 - 187.

9. Wikstrom Shemer E. et al. Intrahepatic cholestasis of pregnancy and associated adverse pregnancy and fetal outcomes: a 12-year population-based cohort study.//B JOG. 2013. Vol. 120, N 6. P. 717 - 723.

10. TOXNET Databases https://www.nlm.nih.gov/toxnet/index.html//Natl. Libr. Med. 2017.

11. Успенская Ю.Б. Современное состояние проблемы холестаза беременных.//Проблемы женского здоровья. 2013. Vol. 8(3): 70 - 6.

12. Wood A.M. et al. Intrahepatic Cholestasis of Pregnancy: A Review of Diagnosis and Management.//Obstet. Gynecol. Surv. 2018. Vol. 73, N 2. P. 103 - 109.

13. Reichert M.C., Lammert F. ABCB4 Gene Aberrations in Human Liver Disease: An Evolving Spectrum.//Semin. Liver Dis. 2018. Vol. 38, N 4. P. 299 - 307.

14. Floreani A. et al. Intrahepatic cholestasis of pregnancy: new insights into its pathogenesis. H J. Matem. Fetal. Neonatal Med. 2013. Vol. 26, N 14. P. 1410 - 1415.

15. Dixon P.H., Williamson C. The pathophysiology of intrahepatic cholestasis of pregnancy.//Clin. Res. Hepatol. Gastroenterol. 2016. Vol. 40, N 2. P. 141 - 153.

16. Sticova E., Jirsa M., Pawlowska J. New Insights in Genetic Cholestasis: From Molecular Mechanisms to Clinical Implications.//Can. J. Gastroenterol. Hepatol. 2018. Vol. 2018. P. 2313675.

17. Ивашкин В.Т. et al. Клинические рекомендации Российской гастроэнтерологической ассоциации и Российского общества по изучению печени по диагностике и лечению холестаза. Российский журнал гастроэнтерологии, гепатологии, колопроктологии. 2015. Vol. 25, N 2. P. 41 - 57.

18. Reyes H. Sex hormones and bile acids in intrahepatic cholestasis of pregnancy.//Hepatology. 2008. Vol. 47, N 2. P. 376 - 379.

19. Majewska A. et al. Association between intrahepatic cholestasis in pregnancy and gestational diabetes mellitus. A retrospective analysis.//Ginekol. Pol. 2019. Vol. 90, N 8. P. 458 - 463.

20. Gen?osmano|lu Turkmen G. et al. Low serum vitamin D level is associated with intrahepatic cholestasis of pregnancy.//J. Obstet. Gynaecol. Res. 2018. Vol. 44, N 9. P. 1712 - 1718.

21. Morton A., Laurie J. The biochemical diagnosis of intrahepatic cholestasis of pregnancy.//Obstet. Med. 2019. Vol. 12, N 2. P. 76 - 78.

22. Herrera C.A. Diagnosis and Management of cholestasis. Pregnancy care. ECHO. April 8th, 2016.

23. Mitchell A. et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study//B JOG An Int. J. Obstet. Gynaecol. 2021. Vol. 128, N 10. P. 1635 - 1644.

24. Ovadia C. et al. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data metaanalyses.//Lancet (London, England). 2019. Vol. 393, N 10174. P. 899 - 909.

25. Cui D. et al. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: A meta-analysis.//J. Obstet. Gynaecol. Res. 2017. Vol. 43, N 9. P. 1411 - 1420.

26. Marschall H.-U. Management of intrahepatic cholestasis of pregnancy.//Expert Rev. Gastroenterol. Hepatol. 2015. Vol. 9, N 10. P. 1273 - 1279.

27. Chappell L.C. et al. Ursodeoxycholic acid versus placebo in women with intrahepatic cholestasis of pregnancy (PITCHES): a randomised controlled trial.//Lancet (London, England). 2019. Vol. 394, N 10201. P. 849 - 860.

28. Girling J., Knight C.L., Chappell L. Intrahepatic cholestasis of pregnancy//BJOG An Int. J. Obstet. Gynaecol. 2022. Vol. 129, N 13.

29. Delgado Nunes V. et al. Intrapartum care of healthy women and their babies: summary of updated NICE guidance//BMJ. 2014. Vol. 349, N dec03 6. P. g6886 - g6886.

30. Batsry L. et al. Perinatal outcomes of intrahepatic cholestasis of pregnancy in twin versus singleton pregnancies: is plurality associated with adverse outcomes?//Arch. Gynecol. Obstet. 2019. Vol. 300, N 4. P. 881 - 887.

31. Zhang Y. et al. Ursodeoxycholic Acid and S-adenosylmethionine for the Treatment of Intrahepatic Cholestasis of Pregnancy: A Meta-analysis.//Hepat. Mon. 2016. Vol. 16, N 8. P. e38558.

32. Kroumpouzos G., Cohen L.M. Specific dermatoses of pregnancy: an evidence-based systematic review.//Am. J. Obstet. Gynecol. 2003. Vol. 188, N 4. P. 1083 - 1092.

33. Gtlney E., Ugar T. Effect of the fetal movement count on maternal-fetal attachment.//Jpn. J. Nuts. Sci. 2019. Vol. 16, N 1. P. 71 - 79.

34. Matsubara S. et al. Perceived fetal movement count as a traditional but essential tool for evaluating fetal health: some additions and Japanese obstetricians' and pediatricians' view.//J. Matem. Fetal. Neonatal Med. 2018. Vol. 31, N 2. P. 251 - 252.

35. Awad N.A. et al. Management and Outcome of Reduced Fetal Movements-is Ultrasound Necessary?//J. Obstet. Gynaecol. Can. 2018. Vol. 40, N 4. P. 454 - 459.

36. Flenady V. et al. Beyond the headlines: Fetal movement awareness is an important stillbirth prevention strategy.//Women Birth. 2019. Vol. 32, N 1. P. 1 - 2.

37. Heazell A.E.P. et al. Alterations in maternally perceived fetal movement and their association with late stillbirth: findings from the Midland and North of England stillbirth case-control study.//BMJ Open. 2018. Vol. 8, N 7. P. e020031.

38. Bryant J., Jamil R.T., Thistle J. Fetal Movement//StatPearls. 2019.

39. Mangesi L. et al. Fetal movement counting for assessment of fetal wellbeing.//Cochrane database Syst. Rev. 2015. Vol. 15; (10): CD, N 10. P. CD004909.

40. Heazell A.E.P. et al. Can promoting awareness of fetal movements and focusing interventions reduce fetal mortality? A stepped-wedge cluster randomised trial (AFFIRM).//BMJ Open. 2017. Vol. 7, N 8. P. e014813.

41. Norman J.E. et al. Awareness of fetal movements and care package to reduce fetal mortality (AFFIRM): a stepped wedge, cluster-randomised trial.//Lancet (London, England). 2018. Vol. 392, N 10158. P. 1629 - 1638.

42. Fleminger J. et al. Ursodeoxycholic acid in intrahepatic cholestasis of pregnancy: a secondary analysis of the PITCHES trial.//BJOG. 2021. Vol. 128, N 6. P. 1066 - 1075.

43. Mashburn S. et al. Intrahepatic cholestasis of pregnancy: risk factors for severe disease.//J. Matem. Fetal. Neonatal Med. 2022. Vol. 35, N 25. P. 8566 - 8570.

44. Ovadia C, Seed FT, Sklavounos AG.V. Association of adverse perinatal outcomes of intrahepatic cholestasis of pregnancy with biochemical markers: results of aggregate and individual patient data meta-analyses.//Lancet (London, England). 2019. Vol. 2; 393 (1017.

45. Geenes V., Williamson C. Intrahepatic cholestasis of pregnancy.//World J. Gastroenterol. 2009. Vol. 15, N 17. P. 2049 - 2066.

46. Mitchell A.L. et al. Re-evaluating diagnostic thresholds for intrahepatic cholestasis of pregnancy: case-control and cohort study.//BJOG. 2021. Vol. 128, N 10. P. 1635 - 1644.

47. Jurate K. et al. Sensitivity and Specificity of Biochemical Tests for Diagnosis of Intrahepatic Cholestasis of Pregnancy.//Ann. Hepatol. 2017. Vol. 16, N 4. P. 569 - 573.

48. Maldonado M. et al. Intrahepatic Cholestasis of Pregnancy Leading to Severe Vitamin К Deficiency and Coagulopathy.//Case Rep. Obstet. Gynecol. 2017. Vol. 2017. P. 5646247.

49. Olsson R. et al. Prolonged postpartum course of intrahepatic cholestasis of pregnancy.//Gastroenterology. 1993. Vol. 105, N 1. P. 267 - 271.

50. Ayta? S., Kargili A., Turkay C. A prolonged gestational intrahepatic cholestasis: a case report.//Turk. J. Gastroenterol. 2006. Vol. 17, N 3. P. 206 - 208.

51. Mohr-Sasson A. et al. The Yield of Abdominal Ultrasound in the Evaluation of Elevated Liver Enzymes during the Second and the Third Trimester of Pregnancy.//Gynecol. Obstet. Invest. 2017. Vol. 82, N 5. P. 517 - 520.

52. Heller M.T. et al. Imaging of hepatobiliary disorders complicating pregnancy.//AJR. Am. J. Roentgenol. 2011. Vol. 197, N 3. P. W528 - 36.

53. Bacq Y., Sentilhes L. Intrahepatic cholestasis of pregnancy: Diagnosis and management.//Clin, liver Dis. 2014. Vol. 4, N 3. P. 58 - 61.

54. Liu X. et al. Perinatal outcomes with intrahepatic cholestasis of pregnancy in twin pregnancies.//J. Matem. Fetal. Neonatal Med. 2016. Vol. 29, N 13. P. 2176 - 2181.

55. Koshida S. et al. Fetal movement frequency and the effect of associated perinatal factors: Multicenter study.//Women Birth. 2019. Vol. 32, N 2. P. 127 - 130.

56. Joshi D. et al. Liver disease in pregnancy.//Lancet (London, England). 2010. Vol. 375, N 9714. P. 594 - 605.

57. Chappell L.C. et al. Does ursodeoxycholic acid improve perinatal outcomes m women with intrahepatic cholestasis of pregnancy?//BMJ. 2018. Vol. 360. P. kl04.

58. Kong X. et al. Evaluating the effectiveness and safety of ursodeoxycholic acid in treatment of intrahepatic cholestasis of pregnancy: A meta-analysis (a prisma-compliant study).//Medicine (Baltimore). 2016. Vol. 95, N 40. P. e4949.

59. Gurung V. et al. Interventions for treating cholestasis in pregnancy.//Cochrane database Syst. Rev. 2013. Vol. 6, N 6. P. CD000493.

60. Shen Y. et al. Is It Necessary to Perform the Pharmacological Interventions for Intrahepatic Cholestasis of Pregnancy? A Bayesian Network Meta-Analysis.//Clin. Drug Investig. 2019. Vol. 39, N 1. P. 15 - 26.

61. Joutsiniemi T. et al. Ursodeoxycholic acid in the treatment of intrahepatic cholestasis of pregnancy: a randomized controlled trial.//Arch. Gynecol. Obstet. 2014. Vol. 289, N 3. P. 541 - 547.

62. Parizek A. et al. Efficacy and safety of ursodeoxycholic acid in patients with intrahepatic cholestasis of pregnancy.//Ann. Hepatol. 2016. Vol. 15, N 5. P. 757 - 761.

63. Pusl T., Beuers U. Intrahepatic cholestasis of pregnancy.//Orphanet J. Rare Dis. 2007. Vol. 2. P. 26.

64. Brites D. Intrahepatic cholestasis of pregnancy: changes in maternal-fetal bile acid balance and improvement by ursodeoxycholic acid.//Ann. Hepatol. 2002. Vol. 1, N 1. P. 20 - 28.

65. Bacq Y. et al. Efficacy of ursodeoxycholic acid in treating intrahepatic cholestasis of pregnancy: a meta-analysis.//Gastroenterology. 2012. Vol. 143, N 6. P. 1492 - 1501.

66. Chappell L.C. et al. Ursodeoxycholic acid versus placebo, and early term delivery versus expectant management, in women with intrahepatic cholestasis of pregnancy: semifactorial randomised clinical trial.//BMJ. 2012. Vol. 344. P. e3799.

67. Zhou F. et al. [Meta-analysis of ursodeoxycholic acid and S-adenosylmethionine for improving the outcomes of intrahepatic cholestasis of pregnancy].//Zhonghua Gan Zang Bing Za Zhi. 2014. Vol. 22, N 4. P. 299 - 304.

68. Wunsch E. et al. Effect of S-adenosyl-L-methionine on liver biochemistry and quality of life in patients with primary biliary cholangitis treated with ursodeoxycholic acid. A prospective, open label pilot study.//J. Gastrointestin. Liver Dis. 2018. Vol. 27, N 3. P. 273 - 279.

69. Girling J. et al. Intrahepatic cholestasis of pregnancy: Green-top Guideline No. 43 June 2022.//B JOG. 2022. Vol. 129, N 13. P. e95 - e114.

70. Reyes H. et al. Steatorrhea in patients with intrahepatic cholestasis of pregnancy.//Gastroenterology. 1987. Vol. 93, N 3. P. 584 - 590.

71. Сидоркевич С.В. В.В.А.В.В.В.И.Д.О. Эфферентные и кровесберегающие технологии в перинатологии. Информ-Навигатор, 2014. 351 р.

72. Кузнецов В.П. Тактика ведения беременных с преэклампсией, осложненной нарушением метаболической функции печени и синдромом эндогенной интоксикации//Автореф. дисс. д-ра мед. наук. 2015. P. 51.

73. Nielsen J.H., Lykke J.A. Differentiated timing of induction for women with intrahepatic cholestasis of pregnancy-A historical cohort study.//Acta Obstet. Gynecol. Scand. 2021. Vol. 100, N 2. P. 279 - 285.

74. Frank Z.C. et al. Timing of Delivery in Intrahepatic Cholestasis of Pregnancy With Total Bile Acids 40 - 99 pmol/L//Obstet. Gynecol. 2020. Vol. 135. P. 156S..

75. Webster J.R. et al. Operative delivery rates following induction of labour for obstetric cholestasis.//Obstet. Med. 2011. Vol. 4, N 2. P. 66 - 69.

76. de Pagter A.G. et al. Familial benign recurrent intrahepatic cholestasis. Interrelation with intrahepatic cholestasis of pregnancy and from oral contraceptives?//Gastroenterology. 1976. Vol. 71, N 2. P. 202 - 207.

77. P. et al. Ursodeoxycholic acid use in lactating female patients is associated with clinically negligible concentrations of this bile acid in breast milk//Scientific Reports. - 2022. - T. 12. - N. 1. - С. 19543

78. Cui D. et al. Bile acid levels and risk of adverse perinatal outcomes in intrahepatic cholestasis of pregnancy: a meta-analysis//Journal of Obstetrics and Gynaecology Research. - 2017. - T. 43. - N. 9. - С. 1411 - 1420.

79. Roberts D., Brown J., Medley N., Dalziel S.R. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane database Syst Rev. 2017; 3: CD004454.

80. Rubagumya D. et al. Intrahepatic cholestasis of pregnancy: Case series of a rare disease in an African setting//SAGE Open Medical Case Reports. - 2022. - T. 10. - С. 2050313X221105832.

81. Edoo A.W.I. et al. A case report of early onset intrahepatic cholestasis of pregnancy//Archives of Disease in Childhood-Fetal and Neonatal Edition. - 2012. - T. 97. - N. Suppl 1. - С. A63-A63.

82. Binder, T., Salaj, P., Zima, T., & , L. (2006). Randomized prospective comparative study of ursodeoxycholic acid and S-adenosyl-L-methionine in the treatment of intrahepatic cholestasis of pregnancy. Journal of Perinatal Medicine, 34 (5). doi: 10.1515/jpm.2006.077